What is GE HealthCare Technologies Inc. worth?
With the base-case assumptions below, a discounted cash flow model on GE HealthCare Technologies Inc.'s reported free cash flow gives $41.48 per share. The share price was $83.64 on November 10, 2026, 102% above that value.
Inputs from the filings
Three sets of assumptions
| Case | Growth yrs 1-5 | Discount rate | Value per share | Value vs price |
|---|---|---|---|---|
| Bear | -1.0% | 10.0% | $19.71 | -76% |
| Base | 4.0% | 9.0% | $41.48 | -50% |
| Bull | 9.0% | 8.0% | $82.12 | -2% |
Sensitivity: base case value per share
| 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | |
|---|---|---|---|---|---|
| 7.0% | $56.95 | $61.65 | $67.39 | $74.56 | $83.79 |
| 8.0% | $45.43 | $48.47 | $52.07 | $56.39 | $61.67 |
| 9.0% | $36.99 | $39.08 | $41.48 | $44.28 | $47.59 |
| 10.0% | $30.56 | $32.04 | $33.72 | $35.64 | $37.85 |
| 11.0% | $25.50 | $26.58 | $27.80 | $29.16 | $30.71 |
Where the presets come from
Base: years 1 to 5 grow at GE HealthCare Technologies Inc.'s revenue growth rate over the last 4 fiscal years (4.1% a year), held between -5% and 15%. Years 6 to 10 grow halfway between that and the long-run rate of 2.5%. Future cash is discounted at 9% a year.
Bear: 5 points less growth, 2% long-run growth, 10% discount rate. Bull: 5 points more growth (at most 25%), 3% long-run growth, 8% discount rate.
Value per share = (present value of 10 years of free cash flow + present value of everything after + cash - debt) / diluted shares.
This is a model run on assumptions, not a recommendation or a price target. Small changes in the discount rate or growth move the result a lot, as the table above shows. Change them yourself in the calculator.
Adjust the assumptions
Move the sliders for growth, long-run growth and discount rate, or switch to average free cash flow, and see the value per share change.
Adjust the assumptions